DT Midstream, Inc. logo DTM - DT Midstream, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 5
SELL 1
STRONG
SELL
0
| PRICE TARGET: $150.14 DETAILS
HIGH: $170.00
LOW: $121.00
MEDIAN: $150.00
CONSENSUS: $150.14
UPSIDE: 22.58%

Stock News

Here Are Thursday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, Amgen, AngloGold Ashanti, Caterpillar, Chewy, Meta Platforms, Novartis, NVIDIA, SK hynix, and More

Here Are Thursday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, Amgen, AngloGold Ashanti, Caterpillar, Chewy, Meta Platforms, Novartis, NVIDIA, SK hynix, and More

Markets are taking a beating as crude oil surges past $100 and Treasury yields hit multi-year highs, setting up a make-or-break inflation report that could seal the Fed's next move. Wall Street analysts are already repositioning across semiconductors, biotech, and energy ahead of the fallout.

Sep 10, 2026 04:09 AM • 247wallst.com
DT Midstream: The Premium Is Backed By A Brownfield Growth Machine

DT Midstream: The Premium Is Backed By A Brownfield Growth Machine

DT Midstream commands a premium valuation due to its shift from gathering to pipeline-focused natural gas infrastructure with dual demand engines: LNG/industrial and utility/data center end markets. DTM's $3.4 billion brownfield project backlog, with 5x–8x build multiples, underpins visible EBITDA growth and justifies the premium versus sector peers trading at lower multiples. Robust dividend coverage (2.3x–2.5x), investment-grade leverage (2.9x–3.5x), and long-term firm contracts (95% of 2025 revenues) support balance sheet strength and cash flow stability.

Aug 03, 2026 03:05 AM • seekingalpha.com
Conestoga SMid Cap Composite Q2 2026 Portfolio Review

Conestoga SMid Cap Composite Q2 2026 Portfolio Review

West Pharmaceuticals stock moved higher following another quarter of broad-based growth, driven by continued demand for high-value biologics packaging and proprietary delivery components. Tyler Technologies underperformed during the quarter despite delivering solid financial results that met management's guidance. We were attracted to Knowles' accelerating organic growth, expanding margins, and exposure to several attractive long-term secular trends.

Jul 31, 2026 04:38 AM • seekingalpha.com

Price Targets